|
Match
|
Document |
Document Title |
|
|
8173607 |
Promoter for the production of hyaluronic acid containing ginsenoside compound K
There are provided a promoter containing ginsenoside compound K for the production of hyaluronic acid, and more particularly, a new efficacy of 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol ...
|
|
|
8168596 |
Use of cycloartane compounds for treating arthritis
A method of treating a disease associated with cartilage defect in a subject in need thereof by administering to the subject an effectively amount of a cycloartane compound of Formula (I).
|
|
|
8163706 |
Method for preparing a centella asiatica extract rich in madecassoside and in terminoloside
The invention concerns an extract of Centella asiatica comprising more than 75 wt. % of a mixture of madecassoside, terminoloside and asiaticoside, relative to the extract total weight, an extract...
|
|
|
8148336 |
Sterol glucoside toxins
The invention relates to the identification of sterol glucoside toxins, and provides methods for detecting and detoxifying the compounds, as well as therapeutic methods for treating subjects...
|
|
|
8088744 |
Cholestanol derivative for combined use
The invention provides a cancer chemotherapeutic agent which has fewer side effects and excellent efficacy. The cancer chemotherapeutic agent of the invention includes a cholestanol derivative...
|
|
|
8080539 |
Method of treating human preeclampsia employing resibufagenin
A method of treating preeclampsia including administering a therapeutically effective dose of resibufagenin to a patient having preeclampsia. Effecting the determination of the presence of...
|
|
|
8048868 |
Method of preventing preeclampsia
A method of preventing preeclampsia including administering to a patient during an early stage of pregnancy a prophylactically-effective amount of resibufogenin. The administration of resibufogenin...
|
|
|
8022044 |
Compositions and methods for therapeutic use
A method and pharmaceutical composition for the enhancement of transfer of a therapeutic agent to a cell wherein the therapeutic agent is formulated in a buffer comprising a compound of Formula I:...
|
|
|
7998936 |
Use of timosaponin Bll in the preparation of a medicament or product for the prevention and treatment of stroke
The invention disclosed the use of timosaponin BII in the preparation of a medicament or product for the prevention and treatment of stroke. The experiments prove that timosaponin BII can improve...
|
|
|
7985818 |
Method to selectively remove safrole from nutmeg oil
Methods for removing safrole from a sample, molecular imprinted copolymers that bind safrole, and methods of making the same are provided.
|
|
|
7973014 |
Medicinal composition containing ginseng secondary glycosides, its preparation method and application
Medicinal composition containing ginseng secondary glycosides, its preparation method and application. The present composition contains mainly, as active ingredients, the ginsenoside with...
|
|
|
7968116 |
Antitumor agent
A sugar-cholestanol compound which can be readily synthesized and which exhibits a satisfactory antitumor activity. An anticancer agent containing, as an active ingredient, a cholestanol compound...
|
|
|
7932233 |
Fungal phytotoxin fusicoccin for the treatment and diagnosis of coagulation-correlated pathologies
The present invention concerns the use of tricyclic terpenes chosen from the group consisting of fusicoccin, ophyobolins or cotylenins for the therapy and diagnosis of coagulation-correlated...
|
|
|
7910557 |
Hair care product
A substance having a testosterone 5α-reductase inhibiting action, a hair papilla cell growth promoting action, a fibroblast growth factor-7 production promoting action, a vascular endothelial ...
|
|
|
7858604 |
Method of treating human volume expansion mediated hypertension employing resibufogenin
A method of treating volume expansion mediated hypertension including administering a therapeutically effective dose of resibufogenin to a patient having volume expansion mediated hypertension. A...
|
|
|
7846904 |
Compositions and methods for increasing telomerase activity
The present invention relates to methods for increasing telomerase activity in cells. Such compositions include pharmaceutical, including topical, and nutraceutical formulations. The method and...
|
|
|
7846905 |
Agent for inhibiting visceral fat accumulation
To reduce amounts of fat accumulated in abdominal cavity and to prevent or ameliorate visceral fat type obesity considered to be a main factor of metabolic syndrome, there is provided an agent or a...
|
|
|
7838500 |
Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments
The invention relates to a crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]
-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, to a method for the preparation thereof,...
|
|
|
7811997 |
Composition containing total triterpenoid sapogenins extracted from bamboo, and the preparation method and use thereof
The invention relates to a composition containing total triterpenoid sapogenins extracted from bamboo, the preparation method and use thereof. These total triterpenoid sapogenins are extracted from...
|
|
|
7767200 |
Cancer treatment using viruses, fluoropyrimidines and camptothecins
Mammalian subjects having a neoplasm are treated with a virus, a fluoropyrimidine, for example 5-fluorouracil, and a camptothecin compound. The virus is selected from the group consisting of a...
|
|
|
7759329 |
Method of treating human preeclampsia employing resibufagenin
A method of treating preeclampsia including administering a therapeutically effective dose of resibufagenin to a patient having preeclampsia. Effecting the determination of the presence of...
|
|
|
7754695 |
Lipase inhibitors
The present invention provides lipase inhibitory agents comprising a gallotannin or ellagitannin component(s) isolated from teas or Tellima grandiflora as well as foods and beverages and medicines...
|
|
|
7745440 |
Pyrazole analogs acting on cannabinoid receptors
One aspect of the invention is concerned with cannabimimetic pyrazole analogs. Another aspect of the invention is concerned with new and improved pyrazole analogs having high affinities and/or...
|
|
|
7666846 |
Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferi
Unique compounds that can be used for inducing an immune response to Borrelia burgdorferi in a subject by administering a therapeutically effective amount of the glycolipid to the subject. Such...
|
|
|
7659310 |
Methods of enhancing solubility of agents
This invention concerns novel methods of enhancing the solubility of a compound. Compositions prepared using such methods are also disclosed. Compositions prepared using the methods have various...
|
|
|
7642246 |
Pure rocuronium bromide
Disclosed herein is rocuronium bromide having a potentiometrical assay of from 99% to 101% in acetic acid and perchloric acid, having less than about 0.2% area by HPLC of...
|
|
|
7538093 |
Compositions and methods for therapeutic use
A method and pharmaceutical composition for the enhancement of transfer of a therapeutic agent to a cell wherein the therapeutic agent is formulated in a buffer comprising a compound of Formula I:...
|
|
|
7534769 |
Compositions and methods for enhancing delivery of therapeutic agents to cells
This invention provides methods and compositions for enhancing transfer of an agent into a cell. The agents can include polypeptides, polynucleotides such as genes and antisense nucleic acids, and...
|
|
|
7534770 |
Glycoside having 4-methylergost-7-en-3-ol skeleton and hyperglycemia improving agent
3-O-β-D-Glucopyranosyl-4-methylergost-7-en-3-ol or a composition containing 0.001% by mass or more of the aforementioned compound, which is an extract of a plant of the family Liliaceae containing ...
|
|
|
7534768 |
Treatment of DNA viral infections
The synergistic combination of a loop diuretic and a cardiac glycoside is useful in the treatment of DNA viral infections.
|
|
|
7531520 |
Drug and food or drink for improving pancreatic functions
3-O-β-D-Glucopyranosyl-4-methyl-ergost-7-en-3-ol or a composition containing 0.001 to 10% by dry mass of the aforementioned compound, which is an extract of a plant of the family Liliaceae or a ...
|
|
|
7507720 |
5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
The invention discloses the use of sapogenin derivatives in the treatment of cognitive disfunction and similar conditions. Methods of treatment and pharmaceutical compositions are also disclosed.
|
|
|
7387805 |
Flavonoid solubilizion agent and method of solubilizing flavonoid
A flavonoid solubilization agent capable of highly solubilizing flavonoids such as isoflavone, baicalin, rutin and naringin whose solubility is generally low; and a method of effecting the above...
|
|
|
7323452 |
Method for the accelerated in vivo removal of ethanol
A method for accelerating the process of removing ethanol from the blood through the use of certain additives that accelerate the metabolic oxidation of ethanol, and others which in addition act as...
|
|
|
7179455 |
Pesticide in gel form
The invention relates to a bait matrix which includes a gelling agent and a pesticide. The bait matrix is useful for controlling pests by attracting and poisoning them. The gel matrix is...
|
|
|
7166611 |
Pharmaceutical compositions having appetite suppressant activity
A pharmaceutical composition contains an extract obtainable from a plant of the genus Trichocaulon or Hoodia containing an appetite suppressant agent having the formula (1). A process for obtaining...
|
|
|
7163702 |
Process for isolating sea cucumber saponin Frondoside A, and immunomodulatory methods of use
This present invention discloses use of a chloroform/solvent mixture extraction at different solvent-to-feed ratios, followed by evaporation and extraction with ethyl acetate/water; followed by...
|
|
|
7160866 |
Isolation of tigogenin pentaglycoside from Chlorophytum nimonii
The present invention provides a novel saponin tigogenin penta glycoside isolated from the aerial parts of Chlorophytum nimonii and a process for the isolation thereof as well as its use in...
|
|
|
7153877 |
Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
A method for preventing and or reducing the symptoms of insulin resistance and a related syndrome in persons comprises identifying persons having or at risk for having such symptoms, and...
|
|
|
7115586 |
Non-inclusion cyclodextrin complexes
The invention provides a number of methods for enhancing the aqueous solubility of an active ingredient which is insoluble or sparingly soluble in water. In one preferred embodiment, solubilization...
|
|
|
7109175 |
Specific steady-state R-type CA2+ channel blockers and use thereof
The present invention relates to Ca2+ channel blockers and more particularly to the R-type Ca2+ channel blockers. More specifically, the invention relates to Ca2+ channel blockers activity of...
|
|
|
7101857 |
Crosslinkable biological material and medical uses
A method for promoting angiogenesis in a patient comprising providing crosslinkable biological solution to the target tissue, wherein the crosslinkable biological solution is loaded with at least...
|
|
|
7094431 |
Method of healing skin wounds in mammals and a composition therefor
This invention pertains to therapeutic antibacterial/antifungal-wound healing compositions comprising a therapeutically effective amount of antibacterial agents and/or antifungal agents and/or...
|
|
|
7091187 |
Compounds, compositions and methods for treatment of inflammatory diseases and conditions
The present invention relates (a) to new compounds represented by Formula I: wherein M represents a macrolide subunit (macrolide moiety) derived from macrolide possessing the property of...
|
|
|
7030094 |
Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21
The invention provides pharmaceutical compositions, particularly vaccine compositions, employing an adjuvant system comprising RC-529 (an aminoalkyl glucosaminide phosphate compound) and QS-21 (a...
|
|
|
7015202 |
Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors
The object of the present invention is to provide the use of glycyrrhizin and its derivatives for inhibition of MCP-1 production. The present invention discloses an MCP-1 production inhibition...
|
|
|
7008929 |
Sapogenin-based treatment
The present invention relates to the use of a sapogenin, chosen from diosgenin and hecogenin, and/or of a plant extract containing at least one of these sapogenins. A preferred use is the treatment...
|
|
|
7001893 |
Inclusion complex of Rifampicin, an anti-tubercular drug, with β-cyclodextrin or 2-hydroxypropyl β-cyclodextrin and a process thereof
The present invention relates to an inclusion complex of Rifampicin and cyclodextrin (CD) that can be used as an anti-tubercular drug. The present invention also relates to a process for...
|
|
|
6992068 |
Cytokine production inhibitors, agents for protecting and promoting liver function, anti-inflammatory agents, immunosuppressants, drugs, cosmetics, foods and food materials
Highly safe cytokine production inhibitors, agents for protecting and promoting liver function, anti-inflammatory agents and immunosuppressants. Brazilian licorice extract and periandrins, which...
|
|
|
6930093 |
Use of ribofuranose derivatives against inflammatory bowel diseases
A method for the prophylaxis or treatment of an inflammatory bowel disease is provided, comprising administering to a patient having or at risk of developing an inflammatory bowel disease a...
|